Chair of Neurosurgery
Brigham and Women's Hospital
Boston, MA, US
I am a physician-scientist, whose clinical and scientific expertise revolves around the surgical/medical treatment of human brain tumors and understanding their biology and applying novel therapeutics to their treatment. My research laboratory focuses mainly on the development and clinical application of oncolytic viruses for the treatment of brain tumors. I have been site PI, national PI and sponsor/PI of multiple gene- based and oncolytic virus clinical trials for Glioblastoma. My laboratory also researches the immunologic and molecular consequences of such approaches in mouse models and human GBM in vitro and in vivo models.
Disclosure(s): Alliance for Cancer Gene Therapy: Grant/Research Support (Ongoing); Bionaut Labs: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Department of Defense: Grant/Research Support (Ongoing); Immunomic Therapeutics: Stock Shareholder (excluding mutual funds) (Ongoing); InSightec: Advisor (Ongoing); NIH: Grant/Research Support (Ongoing); Seneca Therapeutics: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Ternalys Therapeutics: Board Member/Officer/Trustee (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Theriva: Advisor (Ongoing)
Acknowledge of AANS Distinguished Awardee
Sunday, May 5, 2024
8:50 AM – 8:53 AM CT
Contemporary Molecular Landscape, Improved Survival, and Novel Prognostic Factors in 4,400 Gliomas
Sunday, May 5, 2024
2:45 PM – 2:47 PM CT